Patents by Inventor Revital Sasson

Revital Sasson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of protein kinase signaling
    Patent number: 8637575
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Grant
    Filed: June 7, 2009
    Date of Patent: January 28, 2014
    Assignee: Novotyr Therapeutics Ltd.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen
  • Modulators of protein kinase signaling
    Patent number: 8536227
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Grant
    Filed: June 7, 2009
    Date of Patent: September 17, 2013
    Assignee: Novotyr Therapeutics Ltd.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen
  • NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF
    Publication number: 20120083528
    Abstract: The present invention provides new tyrphostin derivatives acting as protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors, and/or which directly or indirectly affect proteins in the PTK-mediated signal transduction pathway, methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PTK and RTK related disorders such as metabolic, fibrotic, and cell proliferative disorders, in particular psoriasis and cancer.
    Type: Application
    Filed: November 10, 2011
    Publication date: April 5, 2012
    Applicant: NOVOTYR THERAPEUTICS LTD.
    Inventors: Hadas Reuveni, Alexander Levitzki, Lilach Steiner, Revital Sasson, Iris Ben-David, Avi Weissberg
  • Protein kinase modulators and therapeutic uses thereof
    Patent number: 8058309
    Abstract: The present invention provides new tyrphostin derivatives acting as substrate competitive protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors, methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PTK and RTK related disorders such as metabolic, fibrotic, and cell proliferative disorders, in particular psoriasis and cancer.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: November 15, 2011
    Assignee: Novotyr Therapeutics Ltd.
    Inventors: Hadas Reuveni, Alexander Levitzki, Lilach Steiner, Revital Sasson, Iris Ben-David, Avi Weissberg
  • NOVEL MODULATORS OF PROTEIN KINASE SIGNALING
    Publication number: 20110105618
    Abstract: The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PK and RK related disorders such as metabolic, inflammatory, fibrotic, and cell proliferative disorders, in particular cancer.
    Type: Application
    Filed: June 7, 2009
    Publication date: May 5, 2011
    Applicant: NOVOTYR THERAPEUTICS LTD.
    Inventors: Hadas Reuveni, Alexander Levitzki, Revital Sasson, Andre C. B. Lucassen
  • NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF
    Publication number: 20100056635
    Abstract: The present invention provides new tyrphostin derivatives acting as substrate competitive protein tyrosine kinase (PTK) inhibitors and receptor tyrosine kinase (RTK) inhibitors, methods of their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for preventions and treatments of PTK and RTK related disorders such as metabolic, fibrotic, and cell proliferative disorders, in particular psoriasis and cancer.
    Type: Application
    Filed: December 4, 2007
    Publication date: March 4, 2010
    Inventors: Hadas Reuveni, Alexander Levitzki, Lilach Steiner, Revital Sasson, Iris Ben-David, Avi Weissberg